Everolimus-Facilitated Reduction Of Tacrolimus Provides Comparable Efficacy And Superior Renal Function Versus Standard Tacrolimus In De Novo Liver Transplant Recipients: 24-Month Results Of A Randomized Trial

被引：0

作者：

Saliba, Faouzi ^{[1
]}

De Simone, Paolo ^{[2
]}

Nevens, Frederik ^{[3
]}

De Carlis, Luciano ^{[4
]}

Metselaar, Herold ^{[5
]}

Beckebaum, Susanne ^{[6
]}

Jonas, Sven ^{[7
]}

Sudan, Debra ^{[8
]}

Fischer, Lutz ^{[9
]}

Fung, John J. ^{[10
]}

Dong, Gaohong ^{[11
]}

Lopez, Patricia M. ^{[12
]}

Junge, Guido ^{[12
]}

机构：

[1] Hop Paul Brousse, Villejuif, France

[2] Azienda Osped Univ Pisana, Pisa, Italy

[3] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium

[4] Osped Niguarda Ca Granda, Milan, Italy

[5] Univ Rotterdam Hosp, Erasmus MC, Rotterdam, Netherlands

[6] Univ Hosp Essen, Essen, Germany

[7] Univ Med Ctr Leipzig, Leipzig, Germany

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[10] Cleveland Clin Fdn, Cleveland, OH 44195 USA

[11] Novartis Pharmaceut, E Hanover, NJ USA

[12] Novartis Pharma AG, Basel, Switzerland

来源：

HEPATOLOGY | 2012年 / 56卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LB5

引用

页码：1519 / 1519

页数：1

共 50 条

[1] Superior Renal Function Sustained for 24 Months through Early Everolimus-Facilitated Reduction of Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients: Results of a Randomized Trial
De Simone, P.
Detry, O.
Kintmalm, G.
Goss, J.
McCormick, P.
Rossi, M.
Moya, A.
Lopez, P.
Junge, G.
Dong, G.
Joseph, D.
Duvoux, C.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 169 - 170
[2] Everolimus-Facilitated Reduction of Tacrolimus Maintains Comparable Efficacy and Better Renal Function Versus Standard Tacrolimus in De Novo Liver Transplant Recipients.
De Simone, P.
Jones, R.
Kohli, V.
Gedaly, R.
Jeffrey, G.
Cantisani, G.
Dong, G.
Joseph, D.
Lopez, P.
Junge, G.
Nevens, F.
LIVER TRANSPLANTATION, 2013, 19 : S131 - S131
[3] Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial
Fung, J.
Chavin, K.
Moysyuk, Y.
Orloff, S.
Yantorno, S.
Jones, R.
Neuhaus, P.
Dong, G.
Lopez, P.
Junge, G.
Nevens, F.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 118 - 118
[4] EVEROLIMUS-BASED IMMUNOSUPPRESSION PROVIDES SUPERIOR RENAL FUNCTION AND COMPARABLE EFFICACY VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMISED CONTROLLED TRIAL
Nevens, F.
De Carlis, L.
Metselaar, H. J.
Kaiser, G. M.
Saliba, F.
Jonas, S.
Duvoux, C.
Dong, G.
Junge, G.
Lopez, P.
De Simone, P.
JOURNAL OF HEPATOLOGY, 2013, 58 : S12 - S12
[5] Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation
Chapman, William C.
Brown, Robert S.
Chavin, Kenneth D.
Sudan, Debra
Koneru, Baburao
Junge, Guido
Dong, Gaohong
Patel, Dharmesh
Teperman, Lewis
Fung, John J.
TRANSPLANTATION, 2017, 101 (02) : 341 - 349
[6] Everolimus-Facilitated Tacrolimus Minimization Preserves Renal Function in De Novo Renal Transplant Recipients
Shihab, F.
Qazi, Y.
Kaplan, B.
Kim, D.
Mulgaonkar, S.
Peddi, V.
Shaffer, D.
Patel, D.
McCague, K.
Vincenti, F.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 538 - 539
[7] EVEROLIMUS PLUS REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS ACHIEVES COMPARABLE OVERALL EFFICACY WITH FEWER BIOPSY-PROVEN ACUTE REJECTIONS VERSUS STANDARD TACROLIMUS: 24-MONTH RESULTS OF A RANDOMIZED TRIAL
Fung, J.
Fischer, L.
Kaiser, G.
Jonas, S.
Heise, M.
Schemmer, P.
Pascher, A.
Schlitt, H.
Paulus, E.
Mertens, M.
Nevens, F.
TRANSPLANT INTERNATIONAL, 2013, 26 : 4 - 4
[8] EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL
De Simone, P.
Fischer, L.
Kaiser, G.
Jonas, S.
Heise, M.
Schemmer, P.
Pascher, A.
Schlitt, H.
Paulus, E.
Mertens, M.
Duvoux, C.
TRANSPLANT INTERNATIONAL, 2013, 26 : 3 - 3
[9] Everolimus-Facilitated Tacrolimus Minimization Preserves Renal Function in De Novo Renal Transplant Recipients.
Shihab, F.
Qazi, Y.
Kaplan, B.
Kim, D.
Mulgaonkar, S.
Peddi, V.
Shaffer, D.
Patel, D.
McCague, K.
Vincenti, F.
TRANSPLANTATION, 2014, 98 : 538 - 539
[10] Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial
Bjorn Nashan
Peter Schemmer
Felix Braun
Markus Dworak
Peter Wimmer
Hans Schlitt
Trials, 16

← 1 2 3 4 5 →